Navigating Drug Discovery in Cancer Treatment

This chapter explores the intricacies of drug discovery for cancer, focusing on the identification of rare antigens and the development of a new platform to mitigate risks. It highlights a collaboration with Gilead to improve therapies for lung adenocarcinoma and breast cancer, while emphasizing the importance of specificity in selecting targets like Ly6G6D for colorectal cancer.